STI LEGACY, INC.

STI LEGACY, INC. specializes in advanced biotechnological research and life sciences innovation for space-based environments, with a focus on tissue engineering, organoid development, and in-orbit manufacturing. The company leverages microgravity conditions to study immunomechanics, extracellular matrix remodeling, and phenotypic switching in human cell models, enabling breakthroughs in cancer research and regenerative medicine. Their technical expertise includes payload integration for low-Earth orbit platforms, real-time biosensing, cryopreservation protocols, and volumetric additive manufacturing of organ analogs. A key differentiator is their ability to translate complex biological phenomena into operational space missions, particularly through virtual tissue analogs and closed-loop experimental systems that replicate human physiological responses under spaceflight stressors. The contractor maintains a deep, sustained partnership with NASA, delivering mission-critical research and development services across multiple human spaceflight programs. Their work supports NASA’s objectives in long-duration spaceflight health, astronaut tissue viability, and in-space biomedical production, consistently contributing to experiments on the International Space Station and future deep space platforms. This relationship reflects a trusted, repeat engagement pattern centered on high-risk, high-reward life science payloads requiring precision engineering and biological fidelity. STI LEGACY’s primary focus lies in NAICS 541714—research and development in biotechnology—where they execute end-to-end bioengineering missions from cell culture design to in-orbit data acquisition. They also support broader life sciences research under NAICS 541712, demonstrating versatility in physical and engineering biology applications. Their market positioning is niche but strategic: a specialized provider of space-adapted biotech solutions for government space and human health programs. As a small business structured as a 2L entity based in Lexington, Kentucky, STI LEGACY operates without federal certifications but maintains a focused, mission-driven presence in the aerospace biotechnology sector, serving as a technical partner for NASA’s most advanced human spaceflight research initiatives.